Candriam SCA’s Affirm AFRM Stock Holding History

Candriam SCA’s Portfolio AFRM Stock Details AFRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Buy	19,124 +596	+3%	+$39K	0.01%	540
2026 Q1	$849K	Buy	18,528 +1,002	+6%	+$57.9K	﹤0.01%	632
2025 Q4	$1.3M	Buy	+17,526	New	+$1.26M	0.01%	556

Other funds holding AFRM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Candriam SCA's AFRM Position: Q2 2026 in Review

Candriam SCA increased its Affirm (AFRM) stake by 3.2% in Q2 2026, buying an estimated $39K and bringing the position to 19,124 shares worth $1.56M. The position accounts for 0.01% of the portfolio, ranked #540.

Candriam SCA first reported a position in AFRM in Q4 2025 and has held it in 3 quarters since. 660 funds tracked by Wall St. Rank hold AFRM as of Q2 2026.

Candriam SCA held 19,124 shares of Affirm worth $1.56M as of Q2 2026.
Candriam SCA bought 596 Affirm shares in Q2 2026, an estimated $39K.
Affirm made up 0.01% of Candriam SCA's portfolio in Q2 2026, its #540 holding.
Candriam SCA first reported a position in Affirm in Q4 2025 and has held it in 3 quarters since.
660 funds tracked by Wall St. Rank held Affirm as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.